about
Cell responses to FGFR3 signalling: growth, differentiation and apoptosisA meckelin-filamin A interaction mediates ciliogenesisA place for precision medicine in bladder cancer: targeting the FGFRs.Identification of genes up-regulated in urothelial tumors: the 67-kd laminin receptor and tumor-associated trypsin inhibitor.A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA geneTwo multiplex assays that simultaneously identify 22 possible mutation sites in the KRAS, BRAF, NRAS and PIK3CA genes.Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancerIn vitro functional effects of XPC gene rare variants from bladder cancer patients.Distinct microRNA alterations characterize high- and low-grade bladder cancerStructure-function studies of an engineered scaffold protein derived from Stefin A. II: Development and applications of the SQT variant.Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients.A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.Patterns of expression of DNA repair genes and relapse from melanoma.High-resolution deletion mapping of 15q13.2-q21.1 in transitional cell carcinoma of the bladder.FGFR1-induced epithelial to mesenchymal transition through MAPK/PLCĪ³/COX-2-mediated mechanisms.Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumorsFibroblast growth factors and their receptors in transitional cell carcinoma.Identification of mutations in distinct regions of p85 alpha in urothelial cancer.European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical Study.Sequence variant on 8q24 confers susceptibility to urinary bladder cancer.Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Tumor suppressor loci in bladder cancer.Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic targetNovel therapeutic targets in bladder cancer: mutation and expression of FGF receptors.Molecular pathogenesis of bladder cancer.Bladder cancer subtypes defined by genomic alterations.Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer.Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival.Use of Aleuria alantia Lectin Affinity Chromatography to Enrich Candidate Biomarkers from the Urine of Patients with Bladder Cancer.Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes.Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup.Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium.Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers.Assessing the quality of studies on the diagnostic accuracy of tumor markers.Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker.Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines.
P50
Q24297423-7FCBC0AD-AF1F-437D-AC7B-923C560EE680Q24298551-CA339FE7-9322-458B-A370-8E4CEE4D8087Q30249143-FBB3142D-F277-45B6-AEEC-0B19C88F42A9Q31150349-4D0A03E1-969D-4E9A-97BF-FAA398288C7FQ33436440-1D1A6506-6DF9-4054-B8C0-6462D4B84C09Q33526301-39CD1E72-A773-4FD7-A8C7-8867FE7D48C6Q33530133-6318ABE2-D195-43A3-808A-F6F7E5014F58Q33554443-58B04E11-B8B9-4DD5-AC45-0AF4D9DF841BQ33805826-A468695F-447C-40E1-8DB0-B197B45322A5Q33854463-B9CB4C78-0CDA-460F-9AF4-45804F42B38FQ33913444-3E571E2B-2750-4B47-B467-A37B5E35FB40Q33937396-6B9501A4-957E-4E3E-8354-2DE89035F202Q34071175-394BC011-80B6-485B-9BE2-FC741F5E9154Q34138714-01A307B4-B348-45F8-8046-07FE1A2AC059Q34273603-2913A85A-F5C0-4018-AD0E-18F667EBF5F5Q34278482-1E100A18-EF59-4E30-B137-8DF43A39B380Q34305855-6BB3A99C-C91A-41EB-87C7-224253524866Q34375736-BC23B4D4-97B4-4186-AC52-2CCAECED5E11Q35051810-1559AEE9-A63E-48DF-AF72-1212FB84F775Q35075756-72D73BC4-E867-4DB7-8D40-8A45F9B61883Q35288237-28A781C3-B46E-40BD-95FA-FFDF6368D3A5Q35752926-555F900B-1ECD-4820-8ACE-7D411626F9C4Q35964294-6810EEAA-9045-4A2B-B503-E5398FE43064Q36341182-43C7346E-EABA-4A4B-8CCB-3C1300F5E9D7Q36664793-362A0F8D-A925-4743-B1E3-92165111B0C5Q36958930-FAF9030E-4A33-4191-B7F9-2ED50C5583BAQ37074139-F369D927-7FA2-421F-B969-CB6EB83E639FQ37243937-BE81CE85-E790-47A5-80A1-AE04EE28D787Q37278990-C2177E41-DD37-419A-B0FA-310A57A03B55Q37331829-50CDB14C-C1FA-4EB6-AC9B-4C99986B471FQ37424329-B5B7E35E-A42D-4F31-A1FF-C5C8D6C62A1FQ37566478-005DE13B-1F44-4795-A6E2-BF672B9BC8FFQ37649062-A0BEC176-A4FB-4126-B44E-66807AFBA96FQ37687627-F99B6362-D4B9-463C-9AE8-20E6E89EF617Q37770780-AB224E6C-3D63-4F7F-89F7-84E0A804FF28Q38084817-2ECCE5D6-E3B9-4E70-9BC0-86250A4C4EB8Q38243470-804673C8-F26C-446A-ACAD-D39DE25FEA47Q38297729-EA1FC224-CCD8-4F02-B207-D3FB68823D59Q38398051-B9ACF387-2D5F-4E2B-8716-BFDD8B32747DQ38489871-57E58775-B1E5-4E34-9B34-E1D90276A14F
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
researcher
@en-gb
Õ°Õ„ÕæÕ”Õ¦ÕøÕæÕøÕ²
@hy
name
Margaret A Knowles
@ast
Margaret A Knowles
@cy
Margaret A Knowles
@en
Margaret A Knowles
@en-gb
Margaret A Knowles
@es
Margaret A Knowles
@nl
Margaret A Knowles
@sl
type
label
Margaret A Knowles
@ast
Margaret A Knowles
@cy
Margaret A Knowles
@en
Margaret A Knowles
@en-gb
Margaret A Knowles
@es
Margaret A Knowles
@nl
Margaret A Knowles
@sl
altLabel
Maggie Knowles
@en
Margaret Knowles
@cy
Margaret Knowles
@en
Margaret Knowles
@en-gb
prefLabel
Margaret A Knowles
@ast
Margaret A Knowles
@cy
Margaret A Knowles
@en
Margaret A Knowles
@en-gb
Margaret A Knowles
@es
Margaret A Knowles
@nl
Margaret A Knowles
@sl
P106
P21
P31
P496
0000-0002-9363-8657